Ashley Gallagher, MA

A newly published review traces chikungunya's re-emergence to a record 2025 outbreak in China, and 2 FDA-approved vaccines shape prevention strategy for pharmacists.

Diyaben Patel, PharmD, discusses where artificial intelligence is genuinely transforming pharmacy practice.

New case-control study finds that patients with type 2 diabetes and more severe depressive symptoms show higher cortisol, higher hemoglobin A1C, and lower insulin.

A new surveillance study shows pneumococcal vaccine shifts cut key antibiotic resistance for invasive pneumococcal disease.

West Nile virus cases rise early in 2026, with Arizona leading with 32 cases.

In-home pharmacist visits uncover medication risks, improve adherence and deprescribing, and help older adults stay safer at home.

Pharmacists are being asked to serve as the frontline correctors of medical misinformation, but the emotional labor and repetition are compounding the severe burnout crisis.

CDC-led VISION interim data show 2025-2026 COVID-19 shots cut adult emergency room visits and hospitalizations.

Data show bone density and lean mass losses can be clinically meaningful, but case reports point to resistance training as effective countermeasures.

FDA staff review recommends against adding 7 peptides to the 503A bulk list, citing gaps in characterization, effectiveness, and safety data.

The filing acceptance marks a step toward lower-cost alternatives to Mounjaro and Zepbound.

Updated charter shifts committee governance to the CDC director and drops fixed meeting schedules.

New analyses from the MAESTRO program and real-world studies bolster the evidence base for the metabolic dysfunction-associated steatohepatitis therapy.

A new sibling-matched cohort study challenges earlier observational data, offering pharmacists evidence-based reassurance to share with pregnant patients.

Coadministering COVID-19 and influenza vaccines did not raise the 90-day risk of serious or clinically meaningful adverse events.

As cases approach the full-year 2025 total, declining vaccination coverage and vaccine hesitancy put pharmacists on the front lines of a public health crisis.

The approval extends risankizumab to children 6 years and older and introduces a new weight-based 55 mg prefilled syringe.

Independent pharmacies turn software into profit through smarter purchasing, real-time benefits, medical billing, and OTC prompts that boost margins and care.

Pharmacists turn summit insights into decisive change, boosting independent pharmacy leadership, clinical care, and readiness for 2026 reform.

Community pharmacists help men overcome care avoidance with walk-in screenings, private consults, and outreach.

Bryan Wheeler, PharmD, discusses how the Medicare GLP-1 Bridge program works and what it means for independent pharmacy operations.

Direct-to-patient drug programs and telehealth reshape pharmacy, and community pharmacists are an essential component.

Pharmacists leverage CGM and automated insulin delivery to personalize diabetes care, prevent errors, and expand equitable access to technology.

AAP challenges HHS as ACIP stalls, leaving pharmacists and health care in limbo on vaccine coverage and respiratory recommendations.

Pharmacies boost profits by embedding clinical service alerts into dispensing workflows and improving documentation.

The first generic rifapentine expands affordable treatment for active and latent tuberculosis.

Retracted vaccine-autism study exposes statistical flaws, reigniting hepatitis B birth-dose debate and highlighting why pharmacists must rely on evidence-based data.

Independent pharmacies boost margins with business insights and smart automation, shifting from dispensing to sustainable growth.

Diabetes technology shifts to continuous glucose monitoring, automated insulin delivery, and connected pens, empowering pharmacists to guide safer care.

Independent pharmacies can profit from immunizations, boosting loyalty and OTC sales with smart vaccine purchasing and efficient workflows.